HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SLCO4C1
solute carrier organic anion transporter family member 4C1
Chromosome 5 · 5q21.1
NCBI Gene: 353189Ensembl: ENSG00000173930.10HGNC: HGNC:23612UniProt: Q6ZQN7
21PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Transporter
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
transmembrane transporter activityextracellular exosomesecondary active transmembrane transporter activitysodium-independent organic anion transportneurodegenerative diseasetype 2 diabetes mellitusdiabetes mellitusrestless legs syndrome
✦AI Summary

SLCO4C1 encodes an organic anion transporter predominantly expressed in kidney proximal tubular cells, where it mediates the transport of various substrates including uremic toxins, steroids, thyroid hormones, and pharmacological compounds 1. The transporter functions independently of sodium, chloride, and ATP, with activity stimulated by acidic extracellular conditions 1. SLCO4C1 plays a crucial role in renal elimination of uremic toxins such as guanidino succinate, asymmetric dimethylarginine (ADMA), and trans-aconitate, helping prevent their accumulation in chr5 kidney disease (CKD) 12. Overexpression of SLCO4C1 in rat kidney models reduced hypertension, cardiomegaly, and renal inflammation while promoting uremic toxin clearance 1. The transporter's expression is regulated by transcriptional mechanisms involving aryl hydrocarbon receptors and can be induced by statins 2. Conversely, uremic toxins like indoxyl sulfate can suppress SLCO4C1 expression through GATA3 upregulation, creating a pathological feedback loop 3. Beyond kidney function, SLCO4C1 has emerged as a hepatic cAMP transporter that inhibits lipogenesis and shows tumor suppressor activity in hepatocellular carcinoma 45. Its promoter methylation serves as a prognostic biomarker in prostate cancer 6.

Sources cited
1
SLCO4C1 eliminates uremic toxins, reduces hypertension and inflammation in renal failure models
PMID: 19875811
2
SLCO4C1 is regulated by statins through aryl hydrocarbon receptors and promotes uremic toxin elimination
PMID: 21656517
3
Indoxyl sulfate downregulates SLCO4C1 through GATA3 upregulation
PMID: 23874392
4
SLCO4C1 acts as hepatic cAMP transporter inhibiting lipogenesis in MASLD
PMID: 41826328
5
SLCO4C1 functions as tumor suppressor in hepatocellular carcinoma
PMID: 38226966
6
SLCO4C1 promoter methylation is prognostic biomarker in prostate cancer
PMID: 31288850
Disease Associationsⓘ20
neurodegenerative diseaseOpen Targets
0.33Weak
type 2 diabetes mellitusOpen Targets
0.32Weak
diabetes mellitusOpen Targets
0.32Weak
restless legs syndromeOpen Targets
0.29Weak
Abnormality of the skeletal systemOpen Targets
0.27Weak
diabetic eye diseaseOpen Targets
0.24Weak
Abruptio PlacentaeOpen Targets
0.23Weak
mixed connective tissue diseaseOpen Targets
0.21Weak
Back painOpen Targets
0.20Weak
cesarean sectionOpen Targets
0.20Weak
femoral neck fractureOpen Targets
0.20Weak
sleep apneaOpen Targets
0.20Weak
duodenitisOpen Targets
0.19Weak
Alzheimer diseaseOpen Targets
0.19Weak
Self-injurious behaviorOpen Targets
0.19Weak
intelligenceOpen Targets
0.12Weak
diabetic polyneuropathyOpen Targets
0.12Weak
placental retentionOpen Targets
0.11Weak
schizophreniaOpen Targets
0.10Suggestive
type 1 diabetes mellitusOpen Targets
0.09Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
SLC75A1Shared pathway100%SLCO5A1Shared pathway100%SLCO6A1Shared pathway100%SLC22A8Protein interaction74%SLC47A1Protein interaction74%SLCO1B3-SLCO1B7Shared pathway50%
Tissue Expression6 tissues
Bone Marrow
100%
Liver
30%
Lung
25%
Heart
2%
Brain
1%
Ovary
0%
Gene Interaction Network
Click a node to explore
SLCO4C1SLC75A1SLCO5A1SLCO6A1SLC22A8SLC47A1SLCO1B3-SLCO1B7
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q6ZQN7
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.01LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.79 [0.62–1.01]
RankingsWhere SLCO4C1 stands among ~20K protein-coding genes
  • #14,018of 20,598
    Most Researched21
  • #9,850of 17,882
    Most Constrained (LOEUF)1.01
Genes detectedSLCO4C1
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Transcriptional regulation of organic anion transporting polypeptide SLCO4C1 as a new therapeutic modality to prevent chronic kidney disease.
PMID: 21656517
J Pharm Sci · 2011
1.00
2
SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.
PMID: 19875811
J Am Soc Nephrol · 2009
0.90
3
Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLD.
PMID: 41826328
Nat Commun · 2026
0.80
4
Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3.
PMID: 23874392
PLoS One · 2013
0.70
5
Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway.
PMID: 32020231
Oncol Rep · 2020
0.60